↓ Skip to main content

Multiple Drug Treatments That Increase cAMP Signaling Restore Long-Term Memory and Aberrant Signaling in Fragile X Syndrome Models

Overview of attention for article published in Frontiers in Behavioral Neuroscience, June 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
105 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Multiple Drug Treatments That Increase cAMP Signaling Restore Long-Term Memory and Aberrant Signaling in Fragile X Syndrome Models
Published in
Frontiers in Behavioral Neuroscience, June 2016
DOI 10.3389/fnbeh.2016.00136
Pubmed ID
Authors

Catherine H. Choi, Brian P. Schoenfeld, Aaron J. Bell, Joseph Hinchey, Cory Rosenfelt, Michael J. Gertner, Sean R. Campbell, Danielle Emerson, Paul Hinchey, Maria Kollaros, Neal J. Ferrick, Daniel B. Chambers, Steven Langer, Steven Sust, Aatika Malik, Allison M. Terlizzi, David A. Liebelt, David Ferreiro, Ali Sharma, Eric Koenigsberg, Richard J. Choi, Natalia Louneva, Steven E. Arnold, Robert E. Featherstone, Steven J. Siegel, R. Suzanne Zukin, Thomas V. McDonald, Francois V. Bolduc, Thomas A. Jongens, Sean M. J. McBride

Abstract

Fragile X is the most common monogenic disorder associated with intellectual disability (ID) and autism spectrum disorders (ASD). Additionally, many patients are afflicted with executive dysfunction, ADHD, seizure disorder and sleep disturbances. Fragile X is caused by loss of FMRP expression, which is encoded by the FMR1 gene. Both the fly and mouse models of fragile X are also based on having no functional protein expression of their respective FMR1 homologs. The fly model displays well defined cognitive impairments and structural brain defects and the mouse model, although having subtle behavioral defects, has robust electrophysiological phenotypes and provides a tool to do extensive biochemical analysis of select brain regions. Decreased cAMP signaling has been observed in samples from the fly and mouse models of fragile X as well as in samples derived from human patients. Indeed, we have previously demonstrated that strategies that increase cAMP signaling can rescue short term memory in the fly model and restore DHPG induced mGluR mediated long term depression (LTD) in the hippocampus to proper levels in the mouse model (McBride et al., 2005; Choi et al., 2011, 2015). Here, we demonstrate that the same three strategies used previously with the potential to be used clinically, lithium treatment, PDE-4 inhibitor treatment or mGluR antagonist treatment can rescue long term memory in the fly model and alter the cAMP signaling pathway in the hippocampus of the mouse model.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Unknown 103 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 19%
Researcher 16 15%
Student > Ph. D. Student 15 14%
Student > Master 9 9%
Unspecified 6 6%
Other 18 17%
Unknown 21 20%
Readers by discipline Count As %
Psychology 18 17%
Biochemistry, Genetics and Molecular Biology 15 14%
Neuroscience 14 13%
Medicine and Dentistry 13 12%
Agricultural and Biological Sciences 8 8%
Other 18 17%
Unknown 19 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2016.
All research outputs
#20,335,423
of 22,880,230 outputs
Outputs from Frontiers in Behavioral Neuroscience
#2,839
of 3,186 outputs
Outputs of similar age
#304,561
of 351,542 outputs
Outputs of similar age from Frontiers in Behavioral Neuroscience
#56
of 68 outputs
Altmetric has tracked 22,880,230 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,186 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,542 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.